InvenireX
InvenireX develops molecular diagnostic technology focused on ultrasensitive DNA detection and absolute quantification. The company provides the R.O.S.A.L.I.N.D platform, which utilizes AI-driven automation and DNA nanotechnology to perform digital PCR and single-molecule counting without the need for enzymes or target amplification. Their products are designed for scientists and researchers requiring high-precision biosensing solutions in both laboratory and field environments.
Visit websiteNewcastle upon Tyne, UK
Healthtech
Biotech
Diagnostics
Nanotechnology
Life Sciences
Funding summary
- Total raised
- €2.9M
- Funding rounds
- 2
Investors in InvenireX
Investors on record for InvenireX. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like InvenireX?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors